S. Benayoun

First name

S.

Last name

Benayoun

Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B. (2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021

View

Azoulay, L., Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., & Suissa, S. (2011). Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol. http://doi.org/10.1016/j.eururo.2011.08.041

View

Lapi, F., Azoulay, L., Niazi, M. T., Yin, H., Benayoun, S., & Suissa, S. (2013). Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. Jama. http://doi.org/10.1001/jama.2013.8638

View

Assayag, J., Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., & Azoulay, L. (2013). Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-012-0132-6

View

Azoulay, L., Eberg, M., Benayoun, S., & Pollak, M. (2015). 5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer. JAMA Oncol. http://doi.org/10.1001/jamaoncol.2015.0387

View

Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B. (2020). Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study. World J Urol. http://doi.org/10.1007/s00345-020-03429-z

View